Companies / Opus Genetics, Inc. / Activity

Activity — Opus Genetics, Inc.

32 moves.

Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
InsidersInstitutions
DateActorActionSecurityValueShares ΔPosition afterImpact
May 18, 2026Foundation Fighting Blindness Retinal Degeneration Fund
Director
SellCommon Stock$7.39M-1.7M
-30.95%
3,792,171
4.56% of shares
medium
Mar 16, 2026Magrath George
CEO
SellCommon Stock$127.3K-24K
-1.38%
1,750,855
2.10% of shares
medium
Apr 23, 2026Magrath George
CEO
SellCommon Stock$49.6K-10K
-0.54%
1,741,344
2.09% of shares
low
Apr 23, 2026Gagnon Robert E.
Executive
SellCommon Stock$40.7K-8K
-1.31%
592,158
0.71% of shares
low
Apr 23, 2026Jayagopal Ashwath
Executive
SellCommon Stock$39.2K-8K
-1.46%
509,233
0.61% of shares
low
Apr 23, 2026Yerxa Benjamin R
Executive
SellCommon Stock$39.1K-7K
-1.04%
711,535
0.86% of shares
low
Apr 23, 2026Schachle Joseph K
Executive
SellCommon Stock$24.5K-5K
-1.56%
296,084
0.36% of shares
low
Mar 16, 2026Schachle Joseph K
Executive
SellCommon Stock$19.5K-4K
-1.22%
300,781
0.36% of shares
low
Mar 16, 2026Jayagopal Ashwath
Executive
SellCommon Stock$19.0K-4K
-0.71%
516,775
0.62% of shares
low
Feb 12, 2026Jayagopal Ashwath
Executive
OtherCommon Stock$18.0K-5K
-1.01%
520,494
0.63% of shares
low
Mar 16, 2026Zaremba Rabourn Amy
Executive
SellCommon Stock$14.8K-3K
-1.46%
190,312
0.23% of shares
low
Apr 23, 2026Zaremba Rabourn Amy
Executive
SellCommon Stock$8.5K-2K
-0.86%
188,671
0.23% of shares
low
Jan 10, 2026Zaremba Rabourn Amy
Executive
OtherCommon Stock$7.6K-4K
-3.47%
110,018
0.13% of shares
low
Jan 18, 2026Zaremba Rabourn Amy
Executive
OtherCommon Stock$7.1K-3K
-3.08%
106,628
0.13% of shares
low
Apr 20, 2026Rodgers Richard J
Director
GrantCommon Stock$0+24K
+7.65%
343,022
0.41% of shares
low
Apr 20, 2026Manuso James S J
Director
GrantCommon Stock$0+24K
+8.32%
317,318
0.38% of shares
low
Apr 20, 2026Graves Adrienne L
Director
GrantCommon Stock$0+24K
+23.62%
127,514
0.15% of shares
low
Apr 20, 2026Gallagher Cam
Director
GrantCommon Stock$0+24K
+1.22%
2,015,797
2.42% of shares
low
Apr 20, 2026Benton Susan
Director
GrantCommon Stock$0+24K
+11.10%
243,894
0.29% of shares
low
Apr 20, 2026Bennett Jean
Director
GrantCommon Stock$0+24K
+10.38%
259,019
0.31% of shares
low
Apr 20, 2026Ainsworth Sean
Director
GrantCommon Stock$0+24K
+8.20%
321,692
0.39% of shares
low
Jan 22, 2026Zaremba Rabourn Amy
Executive
GrantCommon Stock$0+87K
+81.12%
193,128
0.23% of shares
low
Jan 6, 2026Gallagher Cam
Director
GrantCommon Stock$0+67K
+3.48%
1,991,430
2.39% of shares
low
Jan 22, 2026Gagnon Robert E.
Executive
GrantCommon Stock$0+400K
+200.00%
600,000
0.72% of shares
low
Jan 22, 2026Yerxa Benjamin R
Executive
GrantCommon Stock$0+400K
+125.39%
719,005
0.86% of shares
low
Jan 22, 2026Schachle Joseph K
Executive
GrantCommon Stock$0+250K
+458.72%
304,500
0.37% of shares
low
Jan 22, 2026Magrath George
CEO
GrantCommon Stock$0+484K
+37.44%
1,775,293
2.13% of shares
low
Jan 22, 2026Jayagopal Ashwath
Executive
GrantCommon Stock$0+400K
+317.95%
525,807
0.63% of shares
low
Jan 1, 2026Ainsworth Sean
Director
GrantCommon Stock+43K
+16.68%
297,325
0.36% of shares
low
Jan 1, 2026Graves Adrienne L
Director
GrantCommon Stock+24K
+29.74%
103,147
0.12% of shares
low
Jan 1, 2026Manuso James S J
Director
GrantCommon Stock+31K
+11.91%
292,951
0.35% of shares
low
Jan 1, 2026Bennett Jean
Director
GrantCommon Stock+21K
+9.89%
234,652
0.28% of shares
low
← PrevPage 1 of 1Next →